Entero Therapeutics replaces Interim CEO; appoints Jason D. Sawyer

GridAI Technologies Corp.

Richard Joel Paolone terminated as Interim CEO and Chairman, effective Sept 3, 2025, without cause.
Paolone remains as director; consulting agreement terminated with payment in lieu of notice.
Jason D. Sawyer appointed Interim CEO effective Sept 4, 2025; continues as director.
Sawyer has 32-year investment background; currently Head of Finance & M&A at Quantum BioPharma.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.